School of Medicine, Ningbo University,The No.2 Hospital of Ningbo,School of Medicine, Ningbo University,School of Medicine, Ningbo University,School of Medicine, Ningbo University
This work was supported by grants from The National Natural Science Foundation of China (81771166, 81471398), Natural Science Foundation of Zhejiang Province (LY16H090001), Natural Science Foundation of Ningbo (2015A610211), Ningbo Municipal Innovation Team of Life Science and Health (2015C110026), and the K.C.Wong Magna Fund in Ningbo University
Alzheimer’s disease (AD) is a complex multifactorial disease, characterized by progressive cognitive impairments and loss of memory. At present, there is no effective treatment for AD. The neurons differentiated from induced pluripotent stem cells (iPSCs) which are derived from AD patients have the relevant pathological manifestations of AD. Thus iPSCs is one of models for the study of the pathogenesis of AD and for finding the underlying drug target for AD. iPSCs can differentiate into different types of nerve cells to improve the symptoms of AD. The study of iPSCs in AD became an important issue. The advantages of iPSCs as a model in the pathological study of AD and the role of iPSCs in AD treatment were summarized in this article.
WANG Yuan-Yuan, BAO Xiao-Ming, LING Yun-Xiang, WANG Qin-Wen, XU Shu-Jun. Recent Progress of Induced Pluripotent Stem Cells in Alzheimer’s Disease[J]. Progress in Biochemistry and Biophysics,2018,45(6):637-643
Copy® 2024 All Rights Reserved ICP:京ICP备05023138号-1 京公网安备 11010502031771号